- call +1-201-465-4211
- email sales@mrinsights.biz
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks.
Scope of the Report:
The worldwide market for Bipolar Disorders and Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Bipolar Disorders and Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka Holdings
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Mood stabilizer
Anticonvulsant
Antipsychotic
Antidepressant
Antianxiety
Market Segment by Applications, can be divided into
Hospital
Pharmacy
Other
There are 15 Chapters to deeply display the global Bipolar Disorders and Treatment market.
Chapter 1, to describe Bipolar Disorders and Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bipolar Disorders and Treatment, with sales, revenue, and price of Bipolar Disorders and Treatment, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bipolar Disorders and Treatment, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bipolar Disorders and Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bipolar Disorders and Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bipolar Disorders and Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Mood stabilizer
1.2.2 Anticonvulsant
1.2.3 Antipsychotic
1.2.4 Antidepressant
1.2.5 Antianxiety
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Bipolar Disorders and Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Bipolar Disorders and Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Pharmaceuticals
2.3.1 Business Overview
2.3.2 Bipolar Disorders and Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Pharmaceuticals Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Bipolar Disorders and Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allergan
2.5.1 Business Overview
2.5.2 Bipolar Disorders and Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allergan Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Bipolar Disorders and Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 AbbVie
2.7.1 Business Overview
2.7.2 Bipolar Disorders and Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AbbVie Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Otsuka Holdings
2.8.1 Business Overview
2.8.2 Bipolar Disorders and Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Otsuka Holdings Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 AstraZeneca
2.9.1 Business Overview
2.9.2 Bipolar Disorders and Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AstraZeneca Bipolar Disorders and Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bipolar Disorders and Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bipolar Disorders and Treatment Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bipolar Disorders and Treatment Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bipolar Disorders and Treatment Manufacturer Market Share in 2017
3.3.2 Top 6 Bipolar Disorders and Treatment Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bipolar Disorders and Treatment Market Analysis by Regions
4.1 Global Bipolar Disorders and Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Bipolar Disorders and Treatment Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bipolar Disorders and Treatment Revenue and Market Share by Regions (2013-2018)
4.2 North America Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
4.3 Europe Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
4.5 South America Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
5 North America Bipolar Disorders and Treatment by Countries
5.1 North America Bipolar Disorders and Treatment Sales, Revenue and Market Share by Countries
5.1.1 North America Bipolar Disorders and Treatment Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bipolar Disorders and Treatment Revenue and Market Share by Countries (2013-2018)
5.2 United States Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
5.3 Canada Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
5.4 Mexico Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
6 Europe Bipolar Disorders and Treatment by Countries
6.1 Europe Bipolar Disorders and Treatment Sales, Revenue and Market Share by Countries
6.1.1 Europe Bipolar Disorders and Treatment Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bipolar Disorders and Treatment Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
6.3 UK Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
6.4 France Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
6.5 Russia Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
6.6 Italy Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bipolar Disorders and Treatment by Countries
7.1 Asia-Pacific Bipolar Disorders and Treatment Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bipolar Disorders and Treatment Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bipolar Disorders and Treatment Revenue and Market Share by Countries (2013-2018)
7.2 China Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
7.3 Japan Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
7.4 Korea Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
7.5 India Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
8 South America Bipolar Disorders and Treatment by Countries
8.1 South America Bipolar Disorders and Treatment Sales, Revenue and Market Share by Countries
8.1.1 South America Bipolar Disorders and Treatment Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bipolar Disorders and Treatment Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
8.3 Argentina Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
8.4 Colombia Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bipolar Disorders and Treatment by Countries
9.1 Middle East and Africa Bipolar Disorders and Treatment Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bipolar Disorders and Treatment Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bipolar Disorders and Treatment Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
9.3 UAE Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
9.4 Egypt Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
9.5 Nigeria Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
9.6 South Africa Bipolar Disorders and Treatment Sales and Growth Rate (2013-2018)
10 Global Bipolar Disorders and Treatment Market Segment by Type
10.1 Global Bipolar Disorders and Treatment Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bipolar Disorders and Treatment Sales and Market Share by Type (2013-2018)
10.1.2 Global Bipolar Disorders and Treatment Revenue and Market Share by Type (2013-2018)
10.2 Mood stabilizer Sales Growth and Price
10.2.1 Global Mood stabilizer Sales Growth (2013-2018)
10.2.2 Global Mood stabilizer Price (2013-2018)
10.3 Anticonvulsant Sales Growth and Price
10.3.1 Global Anticonvulsant Sales Growth (2013-2018)
10.3.2 Global Anticonvulsant Price (2013-2018)
10.4 Antipsychotic Sales Growth and Price
10.4.1 Global Antipsychotic Sales Growth (2013-2018)
10.4.2 Global Antipsychotic Price (2013-2018)
10.5 Antidepressant Sales Growth and Price
10.5.1 Global Antidepressant Sales Growth (2013-2018)
10.5.2 Global Antidepressant Price (2013-2018)
10.6 Antianxiety Sales Growth and Price
10.6.1 Global Antianxiety Sales Growth (2013-2018)
10.6.2 Global Antianxiety Price (2013-2018)
11 Global Bipolar Disorders and Treatment Market Segment by Application
11.1 Global Bipolar Disorders and Treatment Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Pharmacy Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)
12 Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.1 Global Bipolar Disorders and Treatment Sales, Revenue and Growth Rate (2018-2023)
12.2 Bipolar Disorders and Treatment Market Forecast by Regions (2018-2023)
12.2.1 North America Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.2.2 Europe Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.2.4 South America Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bipolar Disorders and Treatment Market Forecast (2018-2023)
12.3 Bipolar Disorders and Treatment Market Forecast by Type (2018-2023)
12.3.1 Global Bipolar Disorders and Treatment Sales Forecast by Type (2018-2023)
12.3.2 Global Bipolar Disorders and Treatment Market Share Forecast by Type (2018-2023)
12.4 Bipolar Disorders and Treatment Market Forecast by Application (2018-2023)
12.4.1 Global Bipolar Disorders and Treatment Sales Forecast by Application (2018-2023)
12.4.2 Global Bipolar Disorders and Treatment Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bipolar Disorders and Treatment Picture
Table Product Specifications of Bipolar Disorders and Treatment
Figure Global Sales Market Share of Bipolar Disorders and Tre
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
